Rome, November 17th – Danilo Neri, Vice President Operations for PQE Group, […]
A call for Smart Industry by CHIST-ERA on Big Data and Process […]
Why MD Cybersecurity is so important by Danilo Maruccia, Executive Consultant & […]
On September 26th, 2019 the CMDh published the notice “Information on nitrosamines for marketing authorisation holders” asking to all Marketing Authorization Holders (MAHs) of human medicinal products containing chemically synthesised active pharmaceutical ingredients to evaluate the risk of the presence of nitrosamine impurities in their products. This includes generics and over-the counter (OTC) products.
PQE Group has been awarded for the 2nd year in a row, […]
PQE Group presented the documentary ‘Flying Dreams’ on the occasion of the “Festival of Culture – Summer Nights 2019” on the experience lived by the employees in a school in Kathmandu.
Project co-financed under Tuscany POR FESR 2014 – 2020 – Measure 1.1.5
PQE Group was the special guest for “Meet the Champions” event. PQE […]
FDA has issued setting temporary rules on a probable cancer-causing impurity formerly […]
PQE Group is glad to announce the opening of the new office […]